Evaluation of the Impact of an Individual Peer Support Intervention for Stroke Patients When Returning Home: a Mixed Methods Pilot Study (PARADE)
Stroke

About this trial
This is an interventional health services research trial for Stroke focused on measuring Stroke, Peer support
Eligibility Criteria
Inclusion Criteria:
- Adult patient,
- Having had a first confirmed, ischemic or hemorrhagic stroke
- Managed in the participating rehabilitation center
- Whose discharge to home directly from the rehabilitation center is planned
- Presenting a modified Rankin score of 1 to 3 when deciding to leave the stroke center
- Having given its written consent
- Whose main residence is located in the Rhône department
- Aphasic patients may be included if a caregiver can follow up with the case manager
Exclusion Criteria:
- Patient living in an institution prior to stroke
- included in a gerontological network before stroke
- Patient unable to understand quality of life questionnaires
- Patient with unstable medical or psychological conditions who, in the opinion of the investigator, could lead the subject to be non-compliant or uncooperative during the study or could compromise patient safety or participation in the study
- Patient under guardianship or curatorship
- Patient not affiliated to a social health insurance
Sites / Locations
- Hôpital Henry GabrielleRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
intervention group
control group
For 6 months after discharge, patients in the intervention group will benefit from peer support by a trained patient (number and frequency of contacts defined according to the patient's needs). The intervention aims to improve the patient's ability to manage his or her situation and meet his or her needs upon discharge at home, including identifying and seeking for the necessary health or social resources
Patients included in the control group before intervention will receive the usual practices. As part of the study, they will be contacted for data collection 6 months after the transition to home by a clinical research associate.